medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2010, Number s1

Next >>

Cir Gen 2010; 32 (s1)

Neoplasias epiteliales del timo

Santillán-Doherty P, del Campo GLAM

Language: Spanish
References: 21
Page: 75-77
PDF size: 31.89 Kb.


Text Extraction




REFERENCES

  1. Kondo K. Optimal therapy for thymoma. J Med Invest 2008; 55: 17-28.

  2. Casey E, Kiel P, Pharm D, Loehrer P. Clinical management of thymoma patients. Hematol Oncol Clin N Am 2008; 22: 457-473.

  3. Morrissey B, Adams H, Gibbs AR, et al. Percutaneous needle biopsy of the mediastinum: review of 94 procedures. Thorax 1993; 48: 632–7.

  4. Rosado-de-Christenson M, Strollo D, Marom E. Hematol Oncol Clin N Am 2008; 22: 409-431.

  5. Leyvraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985; 312: 1296–9.

  6. Rosado-de-Chrstenson M, Strollo D, Marom E. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin N Am 2008; 22: 409-431.

  7. Kaiser L. Surgical treatment of thymic epithelial neoplasms. Hematol Oncol Clin N Am 2008; 22: 475-488.

  8. Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, Sartori F. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004; 26(2): 412-8.

  9. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In: WHO classification of tumours. 2nd ed. IARC Press, Lyon, 2004: 145-197.

  10. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Torac Surg 2006; 81: 2328-34.

  11. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, et al. WHO Histologic Classification is a Prognostic Indicator in Thymoma. Ann Thorac Surg 2004; 77: 1183-8.

  12. Chen G, Marx A, Chen W, Jiang Y, Puppe B, Stroebel P. New WHO histologic classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 2002; 95: 420–29.

  13. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–92.

  14. Kim D, Yang W, Choi S, Kim K, Chung K. Prognostic and clinical relevance of the World Health Organization Schema for the classification of thymic epithelial tumors. A clinicopathologic study of 108 patients and literature review. Chest 2005; 127: 755-61.

  15. Kondo K, Monden Y. Therapy for Thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003; 76: 878-85.

  16. Gamondes JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: Factors influencing survival. Eur J Cardiothorac Surg 1991; 5: 124–131.

  17. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376–81.

  18. Okumura M, Hiroyuki S, Masato M, Masayoshi I, et al. Clinical and pathological aspects of thymic epithelial tumors. Gen Thorac Cardiovasc Surg 2008; 56: 10-16.

  19. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: A study of 146 consecutive tumors. Am J Surg Pathol 2001; 25: 103–10.

  20. Wick M. Prognostic factors for thymic epithelial neoplasms, with emphasis on tumor staging. Hematol Oncol Clin N Am 2008; 22: 527–542.

  21. Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998; 129: 100–4.




2020     |     www.medigraphic.com